Systems for Mitochondria-Protective Cosmetic Actives: Opportunities in Post-Oncologic Skin Regeneration

Post-oncologic skin is subject to multiple structural and functional impairments following chemotherapy and radiotherapy, including delayed epidermal turnover, compromised barrier integrity, and mitochondrial dysfunction. These changes can lead to persistent dryness, heightened reactivity, impaired regeneration, and reduced patient quality of life. In this context, topical dermocosmetic strategies are essential not only for improving comfort and hydration, but also for supporting key cellular pathways involved in mitochondrial protection and oxidative stress reduction. Despite the promise of natural antioxidant actives, their cutaneous efficacy is often limited by poor stability, low bioavailability, and insufficient penetration of the stratum corneum. The use of nanocarriers promotes deeper skin penetration, protects oxidation-prone antioxidant compounds, and enables a controlled and prolonged release profile. This review summarizes the current evidence (2020–2025) on skin delivery systems designed to enhance the efficacy, stability, and skin penetration of antioxidants. Knowledge gaps and future directions are outlined, highlighting how rationally engineered delivery systems for mitochondria-targeted actives could contribute to safer, more effective strategies for post-oncologic skin regeneration.